The effects of obesity on drug pharmacokinetics in humans

By Morrish Glynn A   Pai Manjunath P   Green Bruce  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 6, 2011-06 ,pp. : 697-706

Informa Healthcare

Access to resources Recommend Favorite

Influence of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Sulfonylurea Drugs

By  

Current Drug Metabolism, Vol. 10, Iss. 6, 2009-07 ,pp. : 643-658

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity

By Jabir Rafid Salim   Naidu Rakesh   Annuar Muhammad Azrif Bin Ahmad   Ho Gwo Fuang   Munisamy Murali   Stanslas Johnson  

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1979-1988

Future Medicine

Access to resources Recommend Favorite

Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review

By van der Zwaluw Carmen S   Engels Rutger CME   Buitelaar Jan   Verkes Robbert J   Franke Barbara   Scholte Ron HJ  

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 853-866

Future Medicine

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Pravastatin: Mechanisms of Pharmacokinetic Events

By Hatanaka T.  

Clinical Pharmacokinetics, Vol. 39, Iss. 6, 2000-12 ,pp. : 397-412

Adis International

Access to resources Recommend Favorite